Synthesis and pharmacokinetic properties of novel cPLA


Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 07 10 2022
revised: 16 11 2022
accepted: 22 11 2022
pubmed: 11 12 2022
medline: 4 1 2023
entrez: 10 12 2022
Statut: ppublish

Résumé

Indole-5-carboxylic acids with 3-aryloxy-2‑oxopropyl residues in position 1 have been shown to be potent inhibitors of cytosolic phospholipase A

Identifiants

pubmed: 36495814
pii: S0968-0896(22)00503-X
doi: 10.1016/j.bmc.2022.117110
pii:
doi:

Substances chimiques

Group IV Phospholipases A2 EC 3.1.1.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117110

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Angelina Subeska (A)

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Jan Althaus (J)

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Theresa Hake (T)

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Walburga Hanekamp (W)

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Dominik Bettenworth (D)

Department of Medicine B, University Hospital Münster, 48149 Münster, Germany.

Dennis Mulac (D)

Institute of Pharmaceutical Technology and Biopharmacy, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Klaus Langer (K)

Institute of Pharmaceutical Technology and Biopharmacy, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.

Matthias Lehr (M)

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany. Electronic address: lehrm@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH